Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 372Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Leukemia 218Hematologic Neoplasms 160Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma 107Myelodysplastic Syndromes 90Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Lymphoma, Non-Hodgkin 66Recurrence 63Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 47Lymphoma, Mantle-Cell 44Multiple Myeloma 42Burkitt Lymphoma 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia, B-Cell 39Neoplasms 38Leukemia, Myeloid, Chronic-Phase 37Lymphoma, B-Cell 36Lymphoma, B-Cell, Marginal Zone 31Hodgkin Disease 29Lymphoma, Large-Cell, Immunoblastic 26Leukemia, Promyelocytic, Acute 23Leukemia, Myelomonocytic, Chronic 21Neoplasms, Plasma Cell 19Myeloproliferative Disorders 19Congenital Abnormalities 19Leukemia, Myelomonocytic, Acute 18Leukemia, Myeloid 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Shock, Septic × Other hematologic neoplasm × Clear all
NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
340 enrolled
Other hematologic neoplasm

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡